drug
Revatio
Marketedupdated 5mo agoby $VTRS Viatris Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 30 investigational indications.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 16, 2028
~2.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (9)
- Dec 24, 2038formulationUS 11337979
- Dec 24, 2038formulationUS 11464778
- Dec 24, 2038formulationUS 11759468
- Dec 24, 2038formulationUS 12005062
- Dec 24, 2038formulationUS 12186321
- Dec 16, 2033formulationUS 11123287
- Dec 16, 2033formulationUS 11123287
- Dec 16, 2033formulationUS 11123287
- Dec 16, 2033formulationUS 11123287
FDA exclusivities (8)
- Jan 31, 2030ODE-469Orphan Drug (7y)3.3y
- Dec 16, 2028NPNP2.2y
- Dec 16, 2028NPNP2.2y
- Dec 16, 2028NPNP2.2y
- Dec 16, 2028NPNP2.2y
- Jan 31, 2026M-287Method (3y)
- Jan 31, 2026M-287Method (3y)
- Jan 31, 2026M-287Method (3y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that